452 related articles for article (PubMed ID: 15817351)
1. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
[TBL] [Abstract][Full Text] [Related]
2. A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases.
Lindvall P; Bergström P; Löfroth PO; Tommy Bergenheim A
Acta Neurochir (Wien); 2009 Sep; 151(9):1053-9. PubMed ID: 19390775
[TBL] [Abstract][Full Text] [Related]
3. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
4. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
7. [Hypofractionated stereotactic radiotherapy for brain metastases].
Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
9. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
Kamath R; Ryken TC; Meeks SL; Pennington EC; Ritchie J; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1467-72. PubMed ID: 15817352
[TBL] [Abstract][Full Text] [Related]
10. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
12. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
15. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
16. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
17. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
18. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
19. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
